Eur Respir J 1994; 7: 515-518
Copyright © ERS Journals Ltd 1994
Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice
PF Piguet
and
C Vesin
Intratracheal instillation of bleomycin (0.08 U) or silica (2 mg) to mice leads, after 15 days, to a patchy pulmonary fibrosis associated with a significant increase of the lung hydroxyproline. Since tumour necrosis factor (TNF) seems to be an important mediator in pulmonary fibrosis, we wondered whether this fibrosis might be prevented by a new TNF-alpha antagonist. Infusion of a 55 kD human recombinant soluble TNF receptor rsTNFR-beta, at a rate of 20 micrograms.day-1, prevented the bleomycin/silica induced increase of lung hydroxyproline content, as measured 15 days after instillation. Infusion of rsTNFR-beta was also effective in the treatment of an established fibrosis, i.e. administered 25 or more days after instillation of bleomycin or silica, since it reduced lung collagen content. Recombinant soluble TNFR-beta had no significant influence on the number of cells, mostly macrophages, recovered by bronchoalveolar lavage. The examination of histological sections indicated that the rsTNFR-beta reduced the proportion of areas of damaged lung and, in silicosis, the formation of nodules with a rich collagen content. This study suggests that rsTNFR-beta might be useful in the therapy of pulmonary fibrosis.
This article has been cited by other articles:

|
 |

|
 |
 
S. Murthy, A. Adamcakova-Dodd, S. S. Perry, L. A. Tephly, R. M. Keller, N. Metwali, D. K. Meyerholz, Y. Wang, M. Glogauer, P. S. Thorne, et al.
Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol,
November 1, 2009;
297(5):
L846 - L855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Failla, T. Genovese, E. Mazzon, M. Fruciano, E. Fagone, E. Gili, A. Barera, C. La Rosa, E. Conte, N. Crimi, et al.
16,16-Dimethyl Prostaglandin E2 Efficacy on Prevention and Protection from Bleomycin-Induced Lung Injury and Fibrosis
Am. J. Respir. Cell Mol. Biol.,
July 1, 2009;
41(1):
50 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Raghu, K. K. Brown, U. Costabel, V. Cottin, R. M. du Bois, J. A. Lasky, M. Thomeer, J. P. Utz, R. K. Khandker, L. McDermott, et al.
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Am. J. Respir. Crit. Care Med.,
November 1, 2008;
178(9):
948 - 955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax,
September 1, 2008;
63(Suppl_5):
v1 - v58.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Koca, A. Isik, I. H. Ozercan, B. Ustundag, B. Evren, and K. Metin
Effectiveness of etanercept in bleomycin-induced experimental scleroderma
Rheumatology,
February 1, 2008;
47(2):
172 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Serrano-Mollar, M. Nacher, G. Gay-Jordi, D. Closa, A. Xaubet, and O. Bulbena
Intratracheal Transplantation of Alveolar Type II Cells Reverses Bleomycin-induced Lung Fibrosis
Am. J. Respir. Crit. Care Med.,
December 15, 2007;
176(12):
1261 - 1268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O.J. Dempsey, K.M. Kerr, L. Gomersall, H. Remmen, and G.P. Currie
Idiopathic pulmonary fibrosis: an update
QJM,
October 1, 2006;
99(10):
643 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Frankel, G. P. Cosgrove, S.-I. Cha, C. D. Cool, M. W. Wynes, B. L. Edelman, K. K. Brown, and D. W. H. Riches
TNF-{alpha} Sensitizes Normal and Fibrotic Human Lung Fibroblasts to Fas-Induced Apoptosis
Am. J. Respir. Cell Mol. Biol.,
March 1, 2006;
34(3):
293 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cavarra, F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci, and G. Lungarella
Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs
Am J Physiol Lung Cell Mol Physiol,
December 1, 2004;
287(6):
L1186 - L1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Carter, L. A. Tephly, S. Venkataraman, L. W. Oberley, Y. Zhang, G. R. Buettner, D. R. Spitz, and G. W. Hunninghake
High Levels of Catalase and Glutathione Peroxidase Activity Dampen H2O2 Signaling in Human Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol.,
July 1, 2004;
31(1):
43 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gambelli, P. Di, X. Niu, M. Friedman, T. Hammond, D. W. H. Riches, and L. A. Ortiz
Phosphorylation of Tumor Necrosis Factor Receptor 1 (p55) Protects Macrophages from Silica-induced Apoptosis
J. Biol. Chem.,
January 16, 2004;
279(3):
2020 - 2029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fujita, J. M. Shannon, O. Morikawa, J. Gauldie, N. Hara, and R. J. Mason
Overexpression of Tumor Necrosis Factor-{alpha} Diminishes Pulmonary Fibrosis Induced by Bleomycin or Transforming Growth Factor-{beta}
Am. J. Respir. Cell Mol. Biol.,
December 1, 2003;
29(6):
669 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Ortiz, F. Gambelli, C. McBride, D. Gaupp, M. Baddoo, N. Kaminski, and D. G. Phinney
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
PNAS,
July 8, 2003;
100(14):
8407 - 8411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Inoue, H. Takano, R. Yanagisawa, T. Yoshikawa, R. Vassallo, E. L. Matteson, and C. F. Thomas Jr.
Effects of Tumor Necrosis Factor-{alpha} Inhibitors on Lung Lesions With Rheumatoid Arthritis
Chest,
July 1, 2003;
124(1):
413 - 414.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Pryhuber, H. L. Huyck, R. Baggs, G. Oberdorster, and J. N. Finkelstein
Induction of Chemokines by Low-Dose Intratracheal Silica Is Reduced in TNFR I (p55) Null Mice
Toxicol. Sci.,
March 1, 2003;
72(1):
150 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kuroki, Y. Noguchi, M. Shimono, K. Tomono, T. Tashiro, Y. Obata, E. Nakayama, and S. Kohno
Repression of Bleomycin-Induced Pneumopathy by TNF
J. Immunol.,
January 1, 2003;
170(1):
567 - 574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ghosh, T. Mendoza, L. A. Ortiz, G. W. Hoyle, C. D. Fermin, A. R. Brody, M. Friedman, and G. F. Morris
Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium
Am. J. Respir. Crit. Care Med.,
September 15, 2002;
166(6):
890 - 897.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Vassallo, E. Matteson, and C. F. Thomas Jr
Clinical Response of Rheumatoid Arthritis-Associated Pulmonary Fibrosis to Tumor Necrosis Factor-{alpha} Inhibition*
Chest,
September 1, 2002;
122(3):
1093 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Haston, M. Wang, R. E. Dejournett, X. Zhou, D. Ni, X. Gu, T. M. King, M. M. Weil, R. A. Newman, C. I. Amos, et al.
Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice
Hum. Mol. Genet.,
August 1, 2002;
11(16):
1855 - 1863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tanino, H. Makita, K. Miyamoto, T. Betsuyaku, Y. Ohtsuka, J. Nishihira, and M. Nishimura
Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice
Am J Physiol Lung Cell Mol Physiol,
July 1, 2002;
283(1):
L156 - L162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Libura, F. Bettens, A. Radkowski, J.M. Tiercy, and P.F. Piguet
Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene
Eur. Respir. J.,
May 1, 2002;
19(5):
912 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. CORBETT, N. MOZZATO-CHAMAY, A. E. BUTTERWORTH, K. M. DE COCK, B. G. WILLIAMS, G. J. CHURCHYARD, and D. J. CONWAY
Polymorphisms in the Tumor Necrosis Factor-alpha Gene Promoter May Predispose to Severe Silicosis in Black South African Miners
Am. J. Respir. Crit. Care Med.,
March 1, 2002;
165(5):
690 - 693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Moore, R. Paine III, P. J. Christensen, T. A. Moore, S. Sitterding, R. Ngan, C. A. Wilke, W. A. Kuziel, and G. B. Toews
Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling
J. Immunol.,
October 15, 2001;
167(8):
4368 - 4377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nemery, A. Bast, J. Behr, P.J.A. Borm, S.J. Bourke, Ph. Camus, P. De Vuyst, H.M. Jansen, V.L. Kinnula, D. Lison, et al.
Interstitial lung disease induced by exogenous agents: factors governing susceptibility
Eur. Respir. J.,
July 1, 2001;
18(32_suppl):
30S - 42s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.J.A. Borm and R.P.F. Schins
Genotype and phenotype in susceptibility to coal workers' pneumoconiosis. The use of cytokines in perspective
Eur. Respir. J.,
July 1, 2001;
18(32_suppl):
127S - 133s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. ORTIZ, J. LASKY, E. GOZAL, V. RUIZ, G. LUNGARELLA, E. CAVARRA, A. R. BRODY, M. FRIEDMAN, A. PARDO, and M. SELMAN
Tumor Necrosis Factor Receptor Deficiency Alters Matrix Metalloproteinase 13/Tissue Inhibitor of Metalloproteinase 1 Expression in Murine Silicosis
Am. J. Respir. Crit. Care Med.,
January 1, 2001;
163(1):
244 - 252.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Fujita, J. M. Shannon, C. G. Irvin, K. A. Fagan, C. Cool, A. Augustin, and R. J. Mason
Overexpression of tumor necrosis factor-{alpha} produces an increase in lung volumes and pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol,
January 1, 2001;
280(1):
L39 - L49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hao, D. A. Cohen, C. D. Jennings, J. S. Bryson, and A. M. Kaplan
Bleomycin-induced pulmonary fibrosis is independent of eosinophils
J. Leukoc. Biol.,
October 1, 2000;
68(4):
515 - 521.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X. Y. ZHANG, S. SHIMURA, T. MASUDA, H. SAITOH, and K. SHIRATO
Antisense Oligonucleotides to NF-kappa B Improve Survival in Bleomycin-induced Pneumopathy of the Mouse
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1561 - 1568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Arai, K.'Y. Abe, H. Matsuoka, M. Yoshida, M. Mori, S. Goya, H. Kida, K. Nishino, T. Osaki, I. Tachibana, et al.
Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo
Am J Physiol Lung Cell Mol Physiol,
May 1, 2000;
278(5):
L914 - L922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gurujeyalakshmi, Y. Wang, and S. N. Giri
Taurine and Niacin Block Lung Injury and Fibrosis by Down-Regulating Bleomycin-Induced Activation of Transcription Nuclear Factor-kappa B in Mice
J. Pharmacol. Exp. Ther.,
April 1, 2000;
293(1):
82 - 90.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Tokuda, M. Itakura, N. Onai, H. Kimura, T. Kuriyama, and K. Matsushima
Pivotal Role of CCR1-Positive Leukocytes in Bleomycin- Induced Lung Fibrosis in Mice
J. Immunol.,
March 1, 2000;
164(5):
2745 - 2751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. King
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement
Am. J. Respir. Crit. Care Med.,
February 1, 2000;
161(2):
646 - 664.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Fujiki, T. Shinbori, M. Suga, H. Miyakawa, and M. Ando
Role of T Cells in Bronchoalveolar Space in the Development of Interstitial Pneumonia Induced by Superantigen in Autoimmune-Prone Mice
Am. J. Respir. Cell Mol. Biol.,
December 1, 1999;
21(6):
675 - 683.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. A. Ortiz, J. A. Lasky, H. Safah, M. Reyes, A. Miller, G. Lungarella, and M. Friedman
Exacerbation of bleomycin-induced lung injury in mice by amifostine
Am J Physiol Lung Cell Mol Physiol,
December 1, 1999;
277(6):
L1239 - L1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Huaux, M. Arras, A. Vink, J.-C. Renauld, and D. Lison
Soluble Tumor Necrosis Factor (TNF) Receptors p55 and p75 and Interleukin-10 Downregulate TNF-alpha Activity during the Lung Response to Silica Particles in NMRI Mice
Am. J. Respir. Cell Mol. Biol.,
July 1, 1999;
21(1):
137 - 145.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. M. W. Janssen-Heininger, I. Macara, and B. T. Mossman
Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)-kappa B . Requirement of Ras/Mitogen-Activated Protein Kinases in the Activation of NF-kappa B by Oxidants
Am. J. Respir. Cell Mol. Biol.,
May 1, 1999;
20(5):
942 - 952.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. S. Davis, L. M. Pfeiffer, and D. R. Hemenway
Expansion of Interferon-gamma -Producing Lung Lymphocytes in Mouse Silicosis
Am. J. Respir. Cell Mol. Biol.,
April 1, 1999;
20(4):
813 - 824.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. A. Ortiz, J. Lasky, G. Lungarella, E. Cavarra, P. Martorana, W. A. Banks, J. J. Peschon, H.-L. Schmidts, A. R. Brody, and M. Friedman
Upregulation of the p75 But Not the p55 TNF-alpha Receptor mRNA after Silica and Bleomycin Exposure and Protection from Lung Injury in Double Receptor Knockout Mice
Am. J. Respir. Cell Mol. Biol.,
April 1, 1999;
20(4):
825 - 833.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Hino, H. Nakamura, S. Abe, H. Saito, M. Inage, K. Terashita, S. Kato, and H. Tomoike
Hydrogen Peroxide Enhances Shedding of Type I Soluble Tumor Necrosis Factor Receptor from Pulmonary Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
January 1, 1999;
20(1):
122 - 128.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. A. Ortiz, K. Moroz, J.-Y. Liu, G. W. Hoyle, T. Hammond, R. F. Hamilton, A. Holian, W. Banks, A. R. Brody, and M. Friedman
Alveolar macrophage apoptosis and TNF-alpha , but not p53, expression correlate with murine response to bleomycin
Am J Physiol Lung Cell Mol Physiol,
December 1, 1998;
275(6):
L1208 - L1218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Liu, D. M. Brass, G. W. Hoyle, and A. R. Brody
TNF-{alpha} Receptor Knockout Mice Are Protected from the Fibroproliferative Effects of Inhaled Asbestos Fibers
Am. J. Pathol.,
December 1, 1998;
153(6):
1839 - 1847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Sime, R. A. Marr, D. Gauldie, Z. Xing, B. R. Hewlett, F. L. Graham, and J. Gauldie
Transfer of Tumor Necrosis Factor-{alpha} to Rat Lung Induces Severe Pulmonary Inflammation and Patchy Interstitial Fibrogenesis with Induction of Transforming Growth Factor-ß1 and Myofibroblasts
Am. J. Pathol.,
September 1, 1998;
153(3):
825 - 832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. MOSSMAN and A. CHURG
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
Am. J. Respir. Crit. Care Med.,
May 1, 1997;
157(5):
1666 - 1680.
[Full Text]
|
 |
|

|
 |

|
 |
 
L. A. Ortiz, H. C. Champion, J. A. Lasky, F. Gambelli, E. Gozal, G. W. Hoyle, M. B. Beasley, A. L. Hyman, M. Friedman, and P. J. Kadowitz
Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappa B and AP-1
Am J Physiol Lung Cell Mol Physiol,
June 1, 2002;
282(6):
L1209 - L1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 by the European Respiratory Society.
|